Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Dubois, Margaux
DOB: 22-JUL-1952 (Age: 73)
Gender: female
Address:
74, boulevard Philippine Schmitt
79360 Saint MarianneVille (France)
ID: 8174-442533-1 (ECI)
Report
Date: 28-AUG-2019
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Cabinet de Médecine Générale
86180 Buxerolles (France)
Specimen
Collected: 28-AUG-2019

Chemistry

Test 28-AUG-2019 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.1 H 4.0 - 5.6 %
Glucose [Mass/volume] in Blood 83.4 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 10.8 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.6 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.8 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.4 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 106.4 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 20.7 L 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c, indicating impaired glucose metabolism or possible prediabetes, despite normal fasting glucose. Renal function, electrolytes, and calcium are within normal limits. Mildly decreased total CO₂ may suggest a tendency toward metabolic acidosis, which should be clinically correlated. No acute abnormalities detected. Recommend monitoring glycemic control and considering further evaluation of acid-base status if clinically indicated.